US-funded vaccine trial on babies cancelled in Guinea-Bissau after uproar
US-funded vaccine trial on babies cancelled in Guinea-Bissau after uproar
US-funded vaccine trial on babies cancelled in Guinea-Bissau after uproar
Key points
اہم نکات
मुख्य बातें
- A US-funded trial that planned to study the hepatitis B vaccine in newborns in Guinea-Bissau has been cancelled after an international outcry over its ethics.
- Critics argued that withholding an established vaccine from some babies would put them at risk of lifelong infection, and the government did not give the project approval.
- The lead researcher confirmed the trial would not go ahead, and officials seized the researchers' vaccines during a search of their offices.
- A US-funded trial that planned to study the hepatitis B vaccine in newborns in Guinea-Bissau has been cancelled after an international outcry over its ethics.
- Critics argued that withholding an established vaccine from some babies would put them at risk of lifelong infection, and the government did not give the project approval.
- The lead researcher confirmed the trial would not go ahead, and officials seized the researchers' vaccines during a search of their offices.
- A US-funded trial that planned to study the hepatitis B vaccine in newborns in Guinea-Bissau has been cancelled after an international outcry over its ethics.
- Critics argued that withholding an established vaccine from some babies would put them at risk of lifelong infection, and the government did not give the project approval.
- The lead researcher confirmed the trial would not go ahead, and officials seized the researchers' vaccines during a search of their offices.
A US-funded trial that planned to study the hepatitis B vaccine in newborns in Guinea-Bissau has been cancelled after an international outcry over its ethics. Critics argued that withholding an established vaccine from some babies would put them at risk of lifelong infection, and the government did not give the project approval. The lead researcher confirmed the trial would not go ahead, and officials seized the researchers' vaccines during a search of their offices. Guinea-Bissau plans to roll out a universal hepatitis B birth dose in 2028.
A US-funded trial that planned to study the hepatitis B vaccine in newborns in Guinea-Bissau has been cancelled after an international outcry over its ethics. Critics argued that withholding an established vaccine from some babies would put them at risk of lifelong infection, and the government did not give the project approval. The lead researcher confirmed the trial would not go ahead, and officials seized the researchers' vaccines during a search of their offices. Guinea-Bissau plans to roll out a universal hepatitis B birth dose in 2028.
A US-funded trial that planned to study the hepatitis B vaccine in newborns in Guinea-Bissau has been cancelled after an international outcry over its ethics. Critics argued that withholding an established vaccine from some babies would put them at risk of lifelong infection, and the government did not give the project approval. The lead researcher confirmed the trial would not go ahead, and officials seized the researchers' vaccines during a search of their offices. Guinea-Bissau plans to roll out a universal hepatitis B birth dose in 2028.
Most read
سب سے زیادہ پڑھی گئی
सबसे ज़्यादा पढ़ी गई
- Loading...
Get news in your inbox
خبریں اپنے ان باکس میں حاصل کریں
खबरें अपने इनबॉक्स में पाएं
One email when new stories are published. No spam, unsubscribe anytime.
نئی خبریں شائع ہونے پر ایک ای میل۔ کوئی سپیم نہیں، کسی بھی وقت ان سبسکرائب کریں۔
नई खबरें प्रकाशित होने पर एक ईमेल। कोई स्पैम नहीं, कभी भी अनसब्सक्राइब करें।